A company description is not available for this instrument.
Research context
Access Bio, Inc appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Access Bio, Inc is currently in a long term uptrend where the price is trading 56.1% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Access Bio, Inc's total revenue rose by 833.7% to $91B since the same quarter in the previous year.
Its net income has increased by 714.5% to $47B since the same quarter in the previous year.
Finally, its free cash flow grew by 77976.9% to $33B since the same quarter in the previous year.
Based on the above factors, Access Bio, Inc gets an overall score of 5/5.